Journal article

Routine versus clinically driven laboratory monitoring and first-line antiretroviral therapy strategies in African children with HIV (ARROW): a 5-year open-label randomised factorial trial.

Abstract:: BACKGROUND: No trials have investigated routine laboratory monitoring for children with HIV, nor four-drug induction strategies to increase durability of first-line antiretroviral therapy (ART). METHODS: In this open-label parallel-group trial, Ugandan and Zimbabwean children or adolescents with HIV, aged 3 months to 17 years and eligible for ART, were randomly assigned in a factorial design. Randomisation was to either clinically driven monitoring or routine laboratory and clinical monitorin...
Expand abstract
Collapse abstract

Actions

Email

Email this record

Send the bibliographic details of this record to your email address.

Your Email
Please enter the email address that the record information will be sent to.

-
Your message (optional)
Please add any additional information to be included within the email.
Share
Cite

Cite this record

APA Style

Kekitiinwa, A., Cook, A., Nathoo, K., Mugyenyi, P., Nahirya-Ntege, P., Bakeera-Kitaka, S., Thomason, M., Bwakura-Dangarembizi, M., Musiime, V., Munderi, P., Naidoo-James, B., Vhembo, T., Tumusiime, C., Katuramu, R., Crawley, J., Prendergast, A., Musoke, P., Walker, A., & Gibb, D. (2013). Routine versus clinically driven laboratory monitoring and first-line antiretroviral therapy strategies in African children with HIV (ARROW): a 5-year open-label randomised factorial trial. Lancet, 381(9875), 1391–1403.

MLA Style

Kekitiinwa, A, et al. “Routine versus Clinically Driven Laboratory Monitoring and First-Line Antiretroviral Therapy Strategies in African Children with HIV (ARROW): a 5-Year Open-Label Randomised Factorial Trial.” Lancet, vol. 381, no. 9875, 2013, pp. 1391–403.

Chicago Style

Kekitiinwa, A, A Cook, K Nathoo, et al. 2013. “Routine versus Clinically Driven Laboratory Monitoring and First-Line Antiretroviral Therapy Strategies in African Children with HIV (ARROW): a 5-Year Open-Label Randomised Factorial Trial.” Lancet 381 (9875): 1391–1403.
Print

Access Document

Publisher copy:: 10.1016/s0140-6736(12)62198-9

Authors

+ Kekitiinwa, A More by this author

Role:: Author

+ Cook, A More by this author

Role:: Author

+ Nathoo, K More by this author

Role:: Author

+ Mugyenyi, P More by this author

Role:: Author

+ Nahirya-Ntege, P More by this author

Role:: Author

More authors...

Journal:: Lancet More from this journal
Volume:: 381
Issue:: 9875
Pages:: 1391-1403
Publication date:: 2013-04-01
DOI:: 10.1016/s0140-6736(12)62198-9
EISSN:: 1474-547X
ISSN:: 0140-6736

Language:: English
Keywords:: ARROW Trial team

Adolescent

CD4 Lymphocyte Count

Humans

Male

Child, Preschool

Child

Female

HIV Infections

Infant

Drug Monitoring

Intention to Treat Analysis

Anti-Retroviral Agents
Pubs id:: pubs:444410
UUID:: uuid:d851d8a3-4be0-43d3-9050-bf056f101f1c
Local pid:: pubs:444410
Source identifiers:: 444410
Deposit date:: 2014-02-08
ARK identifier:: ark:/29072/ora_d851d8a34be043d39050bf056f101f1c

Terms of use

Copyright date:: 2013

Licence:: Terms and Conditions of Use for Oxford University Research Archive

Views and Downloads

Views and downloads will return soon

If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP